Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1246
Peer-review started: August 12, 2015
First decision: September 29, 2015
Revised: October 15, 2015
Accepted: November 9, 2015
Article in press: November 9, 2015
Published online: January 21, 2016
Processing time: 156 Days and 15.9 Hours
Gastrointestinal luminal endoscopy is of paramount importance for diagnosis, monitoring and dysplasia surveillance in patients with both, Crohn’s disease and ulcerative colitis. Moreover, with the recent recognition that mucosal healing is directly linked to the clinical outcome of patients with inflammatory bowel disorders, a growing demand exists for the precise, timely and detailed endoscopic assessment of superficial mucosal layer. Further, the novel field of molecular imaging has tremendously expanded the clinical utility and applications of modern endoscopy, now encompassing not only diagnosis, surveillance, and treatment but also the prediction of individual therapeutic responses. Within this review, we describe how novel endoscopic approaches and advanced endoscopic imaging methods such as high definition and high magnification endoscopy, dye-based and dye-less chromoendoscopy, confocal laser endomicroscopy, endocytoscopy and molecular imaging now allow for the precise and ultrastructural assessment of mucosal inflammation and describe the potential of these techniques for dysplasia detection.
Core tip: Gastrointestinal luminal endoscopy is of paramount importance for diagnosis, monitoring and dysplasia surveillance in patients with Crohn’s disease and ulcerative colitis. Within this review, we describe how novel endoscopic approaches and advanced endoscopic imaging methods such as high definition imaging, high magnification endoscopy, dye-based and dye-less chromoendoscopy, confocal laser endomicroscopy, endocytoscopy and molecular imaging now allow for the accurate and highly resolved assessment of mucosal inflammation on the cellular level and describe the potential of these techniques for dysplasia detection.